P
Periman Eye Institute | Seattle, WA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
AR-15512
SAF312
Dupilumab
TP-03
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 7 total trials
To evaluate dry eye symptoms and contact lens wearing times after a single iLux treatment by evaluating change from baseline in OSDI scores, subjecti...
Enrolling
Dry Eye
Meibomian Gland Dysfunction
Procedure: Systane iLux thermal pulsation treatment
This is a multi-center, double-masked, randomized, placebo-controlled, parallel-group, efficacy, safety, and tolerability study evaluating the effica...
Enrolling
Atopic Keratoconjunctivitis
Drug: Dupilumab
iTEAR generation 2 will be supplied t eligible subjects at Day 0. At Day 30, symptom questionnaires and ophthalmic exam will be performed.
Enrolling
Dry Eye
Device: iTEAR100 treatment
Trial sponsors
A
O
P
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems